Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Asia Medical and Agricultural Laboratory and Research Center PCL Forward PE Ratio Related Terms
Asia Medical and Agricultural Laboratory and Research Center PCL Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asia Medical and Agricultural Laboratory and Research Center PCL Forward PE Ratio Chart
Asia Medical and Agricultural Laboratory and Research Center PCL Annual Data
Trend
2024-12
2025-12
Forward PE Ratio
15.63
7.37
Asia Medical and Agricultural Laboratory and Research Center PCL Quarterly Data
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
15.63
12.20
21.60
9.66
7.37
8.36
BKK:AMARC vs COHR, KEYS, GRMN: Forward PE Ratio Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asia Medical and Agricultural Laboratory and Research Center PCL Forward PE Ratio vs Hardware Industry
Asia Medical and Agricultural Laboratory and Research Center PCL Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) has a Forward PE Ratio of 7.49 as of Aug. 09, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Asia Medical and Agricultural Laboratory and Research Center PCL and its competitors. According to the industry distribution chart, Asia Medical and Agricultural Laboratory and Research Center PCL ranks #77 out of 1022 companies in the Hardware industry, placing it in the top 7.5%.
Is Asia Medical and Agricultural Laboratory and Research Center PCL's Forward PE Ratio too high?
Asia Medical and Agricultural Laboratory and Research Center PCL's current Forward PE Ratio is 7.49. The Hardware industry median Forward PE Ratio is 21.67. Asia Medical and Agricultural Laboratory and Research Center PCL's value of 7.49 is 65.4% below this industry median. Based on the distribution chart, Asia Medical and Agricultural Laboratory and Research Center PCL ranks #77 out of 1022 companies in the Hardware industry, which is in the top quartile — a strong position relative to peers. Overall, Asia Medical and Agricultural Laboratory and Research Center PCL has a GF Score™ of 91/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asia Medical and Agricultural Laboratory and Research Center PCL's Forward PE Ratio compare to COHR and KEYS?
According to the Hardware industry distribution chart, Asia Medical and Agricultural Laboratory and Research Center PCL ranks #77 out of 1022 companies for Forward PE Ratio. This places Asia Medical and Agricultural Laboratory and Research Center PCL in the top 8% of its industry — outperforming the majority of peers. The industry median Forward PE Ratio is 21.67. Asia Medical and Agricultural Laboratory and Research Center PCL's value of 7.49 is 65.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Hardware company?
The median Forward PE Ratio among Hardware companies is 21.67, based on 1,022 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asia Medical and Agricultural Laboratory and Research Center PCL's current Forward PE Ratio of 7.49 is 65.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Asia Medical and Agricultural Laboratory and Research Center PCL and its competitors. For the Hardware industry, the median Forward PE Ratio is 21.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asia Medical and Agricultural Laboratory and Research Center PCL's current Forward PE Ratio is 7.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asia Medical and Agricultural Laboratory and Research Center PCL stock overvalued right now?
Based on GuruFocus' analysis, Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) is currently considered Modestly Overvalued. The stock's GF Value™ is ฿2.61, compared to a current price of ฿2.92 — trading 11.9% above its estimated fair value. The current Forward PE Ratio is 7.49 and 65.4% below the Hardware industry median of 21.67. Asia Medical and Agricultural Laboratory and Research Center PCL's overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC), the current Forward PE Ratio is 7.49 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) Overvalued in 2026?
Based on GuruFocus' analysis, Asia Medical and Agricultural Laboratory and Research Center PCL stock appears to be overvalued.
The current stock price of ฿2.92 is trading 11.9% above its estimated GF Value™ of ฿2.61.
GuruFocus considers Asia Medical and Agricultural Laboratory and Research Center PCL to be Modestly Overvalued.
Key valuation signals for BKK:AMARC:
Forward PE Ratio: 7.49
GF Value™: ฿2.61 vs. price of ฿2.92 (11.9% above fair value)
Industry Position: 65.4% below the Hardware median (#77 of 1022)
No single metric tells the full story. See the BKK:AMARC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asia Medical and Agricultural Laboratory and Research Center PCL is engaged in providing comprehensive scientific services for the agriculture, food, pharmaceutical and environment sectors including testing, calibration, inspection and certification according to international quality standards. The company geographically operates only in Thailand.
91GF Score
Get the complete analysis for BKK:AMARC
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:AMARC has been successfully added to your 
